BJ
FCSC

BlackRock Japan’s Fibrocell Science Inc. FCSC Stock Holding History

BlackRock Japan’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-210
Closed -$8K – 1417
2014
Q4 		$8K Buy
+210
New +$8.49K ﹤0.01% 1285

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $5.37B AUM 18.53% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return

BlackRock Japan's FCSC Position: Q1 2015 in Review

BlackRock Japan sold out of Fibrocell Science Inc. (FCSC) in Q1 2015, closing a stake of 210 shares — an estimated $8K sold.

BlackRock Japan first reported a position in FCSC in Q4 2014 and held it in 1 quarter. The position peaked at $8K in Q4 2014. 39 funds tracked by Wall St. Rank hold FCSC as of Q1 2015.

  • BlackRock Japan reported no remaining Fibrocell Science Inc. position as of Q1 2015 after selling out during the quarter.
  • BlackRock Japan sold 210 Fibrocell Science Inc. shares in Q1 2015, an estimated $8K.
  • BlackRock Japan first reported a position in Fibrocell Science Inc. in Q4 2014 and held it in 1 quarter.
  • BlackRock Japan's Fibrocell Science Inc. position peaked at $8K in Q4 2014.
  • 39 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2015.

Based on BlackRock Japan's 13F filing for Q1 2015, filed 13 May 2015.